What is happening in health technology, and what is happening here: the analysis behind the episodes, the studies we publish, the programmes we run with our clients, and the moves worth knowing about across the ecosystem.
The tools were already there. What was missing was a reason to open them on a Tuesday morning. Inside the programme that turned a licence roll-out into a working community, and the three things we would do differently next time.
From the first equations written on paper in 1964 to AlphaFold and the Nobel prize.
Two years of public announcements from 62 companies, read systematically. Free to download.
Ten years after the prediction, the profession has grown. What the forecast got wrong.
23andMe turned biological intimacy into an asset. Then the asset was sold.
Grant success rates are collapsing. Decentralised science says it has an answer.
Pear Therapeutics had the evidence and the clearance. Reimbursement decided otherwise.
Interviews recorded on the floor, published the same week. Tell us who we should talk to.
Sixty-two companies followed, every entry sourced, refreshed daily without anyone touching it.
Second edition, in Paris. Programme and speakers announced in October.
Three weeks, a maturity score by department, and a prioritised adoption roadmap.
